fda warning about semaglutide warns safety of 'off-brand' versions of Ozempic, Wegovy FDA Adds New Warning for

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist, working by imitating the activity of the GLP-1 hormone

In 2015, before the FDA approved synthetic GLP-1s for weight loss and researchers linked them to cardiovascular, kidney, and lung function, Rodrigo Mansur, a psychiatrist at the University of Toronto, hypothesized that GLP-1 drugs might help treat mental illness

This is an important point that can help reduce concerns for individuals with sulfa allergies who might be hesitant to take semaglutide

Being overweight or obese can increase your health risks like hypertension, type 2 diabetes, and heart disease